Abstract
PURPOSE: To comprehensively assess Checklist for Artificial Intelligence in Medical Imaging (CLAIM) adherence in medical imaging artificial intelligence (AI) literature by aggregating data from previous systematic and non-systematic reviews. METHODS: A systematic search of PubMed, Scopus, and Google Scholar identified reviews using the CLAIM to evaluate medical imaging AI studies. Reviews were analyzed at two levels: review level (33 reviews; 1,458 studies) and study level (421 unique studies from 15 reviews). The CLAIM adherence metrics (scores and compliance rates), baseline characteristics, factors influencing adherence, and critiques of the CLAIM were analyzed. RESULTS: A review-level analysis of 26 reviews (874 studies) found a weighted mean CLAIM score of 25 [standard deviation (SD): 4] and a median of 26 [interquartile range (IQR): 8; 25(th)-75(th) percentiles: 20-28]. In a separate review-level analysis involving 18 reviews (993 studies), the weighted mean CLAIM compliance was 63% (SD: 11%), with a median of 66% (IQR: 4%; 25(th)-75(th) percentiles: 63%-67%). A study-level analysis of 421 unique studies published between 1997 and 2024 found a median CLAIM score of 26 (IQR: 6; 25(th)-75(th) percentiles: 23-29) and a median compliance of 68% (IQR: 16%; 25(th)-75(th) percentiles: 59%-75%). Adherence was independently associated with the journal impact factor quartile, publication year, and specific radiology subfields. After guideline publication, CLAIM compliance improved (P = 0.004). Multiple readers provided an evaluation in 85% (28/33) of reviews, but only 11% (3/28) included a reliability analysis. An item-wise evaluation identified 11 underreported items (missing in ≥50% of studies). Among the 10 identified critiques, the most common were item inapplicability to diverse study types and subjective interpretations of fulfillment. CONCLUSION: Our two-level analysis revealed considerable reporting gaps, underreported items, factors related to adherence, and common CLAIM critiques, providing actionable insights for researchers and journals to improve transparency, reproducibility, and reporting quality in AI studies. CLINICAL SIGNIFICANCE: By combining data from systematic and non-systematic reviews on CLAIM adherence, our comprehensive findings may serve as targets to help researchers and journals improve transparency, reproducibility, and reporting quality in AI studies.